[Effects of a novel antiprogestin derivative ZXH951 on proliferation and telomerase activity of human breast carcinoma cell lines].

To investigate the antiproliferative activity of a new synthetic steroid ZXH951 structurally related to mifepristone (RU486) and its effects on cell cycle traverse and telomerase activity in human breast carcinoma cell lines.
Antiproliferative activity was determined by cell growth curve, MTT reduction and colony formation. Receptor binding affinities were measured by competitive binding assay using radiolabelled ligands. Cell cycle distribution was analyzed by flow cytometry. Telomerase activity was investigated by TRAP-PCR.
ZXH951 exhibited potent antiproliferative activity in estrogen receptor and progesterone receptor positive human breast carcinoma cell lines in vitro, high affinity with human progesterone receptor-A, little affinity with estrogen receptor and blockade the cells in G1 phase. Moreover, when T47D cells were exposed to 0.4, 1.0 and 10 mumol.L-1 of ZXH951 for 72 h, the telomerase activity was significantly decreased.
ZXH951 is a promising progesterone receptor antagonist. It significantly inhibits the growth of estrogen receptor and progesterone receptor positive human breast carcinoma cells. Its mechanism of action may be related to its antiproliferation mediated by progesterone receptor and inhibition of telomerase activity.
AuthorsL E Zhou, R Han
JournalYao xue xue bao = Acta pharmaceutica Sinica (Yao Xue Xue Bao) Vol. 35 Issue 10 Pg. 733-8 (Oct 2000) ISSN: 0513-4870 [Print] China
PMID11372437 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Hormone Antagonists
  • Receptors, Progesterone
  • Steroids
  • ZXH951
  • Telomerase
  • Breast Neoplasms (enzymology)
  • Female
  • Hormone Antagonists (pharmacology)
  • Humans
  • Receptors, Progesterone (antagonists & inhibitors)
  • Steroids (pharmacology)
  • Telomerase (drug effects)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: